IPSWICH, Mass., Nov. 1, 2011 /PRNewswire/ -- New England Biolabs (NEB), a world leader in the production and supply of reagents for the life science industry, has made its popular web tools, Double Digest Finder and Enzyme Finder, available as the "NEB Tools" app for Android™ phones and tablets. These tools, designed to help set up restriction enzyme experiments, have already been downloaded from the Apple® App Store(SM) by more than 12,000 researchers. Download the new NEB Tools app from the Android Market™ by visiting: www.neb.com/androidtools.
The Double Digest Finder recommends optimum conditions for a double digest, including buffer, incubation temperature and supplement requirements. Simple scrolling lists allow users to quickly choose two enzymes and access all the information they need to perform double digests.
NEB's Enzyme Finder sorts restriction enzymes by category, sequence or name, and provides you detailed information for each enzyme. The tool contains links directly to the NEB website, and can email results directly to the user.
"Without leaving the bench, biologists who have an Android device can use the NEB Tools app to access key information on restriction enzymes in a convenient format," says Ruben Melo, Business Systems Manager at New England Biolabs. "Release of this Android app is part of New England Biolabs' mission to develop both biological and digital technologies that enhance how scientists can design and execute experiments."
Updates are planned to the NEB Tools app, for both Apple and Android device users, as NEB further enhances existing tools and develops new ones.
Android and Android Market are trademarks of Google, Inc. Apple is a trademark and App Store is a service mark of Apple, Inc.
Established in the mid 1970's, New England Biolabs, Inc. is the industry leader in the discovery and production of enzymes for molecular biology applications and now offers the largest selection of recombinant and native enzymes for genomic research. NEB continues to expand its product offerings into areas related to PCR, gene expression, sample preparation for next generation sequencing, cellular analysis, epigenetics and RNA analysis. Additionally, NEB is focused on strengthening alliances that enable new technologies to reach key market sectors. New England Biolabs is a privately held company, headquartered in Ipswich, MA and has extensive worldwide distribution through a network of exclusive distributors, agents and six subsidiaries located in Canada, China, France, Germany, Japan and the UK. For more information about New England Biolabs visit www.neb.com
SOURCE New England Biolabs